GSA CAPITAL PARTNERS LLP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$871,000
+197.3%
54,582
+156.4%
0.12%
+163.6%
Q2 2022$293,000
-62.4%
21,289
-40.4%
0.04%
-55.1%
Q4 2021$779,000
+112.3%
35,704
+433.0%
0.10%
+63.3%
Q4 2020$367,000
-21.6%
6,699
-67.3%
0.06%
-23.1%
Q3 2020$468,00020,4660.08%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders